Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael E Ray

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Urology|February 8, 2006
Clonality of sarcomatous and carcinomatous elements in sarcomatoid carcinoma of the prostateMichael E Ray, Kirk J Wojno, Neal S Goldstein, et al.
Journal of the National Cancer Institute|February 13, 2009
Potential surrogate endpoints for prostate cancer survival: analysis of a phase III randomized trialMichael E Ray, Kyounghwa Bae, Maha H A Hussain, et al.
Cancer Research|January 20, 2004
Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell linesMichael E Ray, Zeng Quan Yang, Donna Albertson, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2007
Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancerJames D Murphy, Saroja Adusumilli, Kent A Griffith, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 2007
Long-term outcomes after radiotherapy for retroperitoneal and deep truncal sarcomaMary Feng, James Murphy, Kent A Griffith, et al.
International Journal of Radiation Oncology, Biology, Physics|August 30, 2008
Loss of Raf kinase inhibitory protein induces radioresistance in prostate cancerKathleen M Woods Ignatoski, Navdeep K Grewal, Sonja M Markwart, et al.
Urology|March 1, 2008
Impact of common iliac nodal treatment on radiation outcomes in localized prostate cancerDaniel E Soto, Scott Glaser, Rebecca H Roberts, et al.
Cancer|June 24, 2006
Primary versus radiation-associated craniofacial osteosarcoma: Biologic and clinicopathologic comparisonsJonathan B McHugh, Dafydd G Thomas, Joseph M Herman, et al.
Radiation Oncology (London, England)|June 12, 2012
Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapyJeffrey Vainshtein, Eyad Abu-Isa, Karin B Olson, et al.
Urology|December 5, 2006
Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failureMichael E Ray, Larry B Levy, Eric M Horwitz, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Urology|February 8, 2006
Clonality of sarcomatous and carcinomatous elements in sarcomatoid carcinoma of the prostateMichael E Ray, Kirk J Wojno, Neal S Goldstein, et al.
Journal of the National Cancer Institute|February 13, 2009
Potential surrogate endpoints for prostate cancer survival: analysis of a phase III randomized trialMichael E Ray, Kyounghwa Bae, Maha H A Hussain, et al.
Cancer Research|January 20, 2004
Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell linesMichael E Ray, Zeng Quan Yang, Donna Albertson, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2007
Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancerJames D Murphy, Saroja Adusumilli, Kent A Griffith, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 2007
Long-term outcomes after radiotherapy for retroperitoneal and deep truncal sarcomaMary Feng, James Murphy, Kent A Griffith, et al.
International Journal of Radiation Oncology, Biology, Physics|August 30, 2008
Loss of Raf kinase inhibitory protein induces radioresistance in prostate cancerKathleen M Woods Ignatoski, Navdeep K Grewal, Sonja M Markwart, et al.
Urology|March 1, 2008
Impact of common iliac nodal treatment on radiation outcomes in localized prostate cancerDaniel E Soto, Scott Glaser, Rebecca H Roberts, et al.
Cancer|June 24, 2006
Primary versus radiation-associated craniofacial osteosarcoma: Biologic and clinicopathologic comparisonsJonathan B McHugh, Dafydd G Thomas, Joseph M Herman, et al.
Radiation Oncology (London, England)|June 12, 2012
Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapyJeffrey Vainshtein, Eyad Abu-Isa, Karin B Olson, et al.
Urology|December 5, 2006
Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failureMichael E Ray, Larry B Levy, Eric M Horwitz, et al.
Pageof 3